Vulnerability Description
LRM contains a directory traversal vulnerability that can allow a malicious actor to upload outside the intended directory structure.
CVSS Score
CRITICAL
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Illumina | Local Run Manager | >= 1.3, <= 3.1 |
| Illumina | Iseq 100 | - |
| Illumina | Miniseq | - |
| Illumina | Miseq | - |
| Illumina | Miseq Dx | - |
| Illumina | Nextseq 500 | - |
| Illumina | Nextseq 550 | - |
| Illumina | Nextseq 550Dx | - |
Related Weaknesses (CWE)
References
- https://www.cisa.gov/uscert/ics/advisories/icsa-22-153-02Third Party AdvisoryUS Government Resource
- https://www.cisa.gov/uscert/ics/advisories/icsa-22-153-02Third Party AdvisoryUS Government Resource
FAQ
What is CVE-2022-1518?
CVE-2022-1518 is a vulnerability with a CVSS score of 10.0 (CRITICAL). LRM contains a directory traversal vulnerability that can allow a malicious actor to upload outside the intended directory structure.
How severe is CVE-2022-1518?
CVE-2022-1518 has been rated CRITICAL with a CVSS base score of 10.0/10. This is considered a critical vulnerability requiring immediate attention.
Is there a patch for CVE-2022-1518?
Check the references section above for vendor advisories and patch information. Affected products include: Illumina Local Run Manager, Illumina Iseq 100, Illumina Miniseq, Illumina Miseq, Illumina Miseq Dx.